Company Filing History:
1 out of 14 
1 out of 378 
Years Active: 2011
Title: Thomas Herget: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Herget is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aminopyrimidine derivatives. His research focuses on developing new therapeutic agents for various diseases.
Latest Patents
Thomas Herget holds a patent for "Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases." This invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof. The patent outlines their use as active agents for the prophylaxis and treatment of infectious diseases, autoimmune diseases, cardiovascular diseases, and more. The invention also discusses the use of these derivatives as inhibitors for protein kinases, highlighting their potential in medical applications.
Career Highlights
Throughout his career, Thomas Herget has worked with prominent companies in the pharmaceutical industry. He has been associated with Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft. His work in these organizations has contributed to advancements in drug discovery and development.
Collaborations
Thomas has collaborated with notable professionals in his field, including Axel Choidas and Alexander Backes. These collaborations have further enriched his research and innovation efforts.
Conclusion
Thomas Herget is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases significantly. His innovative approach to developing aminopyrimidine derivatives showcases his commitment to advancing medical science.